State Of Alaska, Department Of Revenue Supernus Pharmaceuticals, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.42 Billion
- Q3 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 31,456 shares of SUPN stock, worth $1.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,456
Previous 32,313
2.65%
Holding current value
$1.16 Million
Previous $864,000
13.43%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding SUPN
# of Institutions
281Shares Held
60.6MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$384 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$226 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$188 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$106 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$97.1 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.97B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...